摘要
卒中是全球严重的公共健康问题，缺血性卒中占其中的60％-80％。众所皆知，缺血性卒中拥有高复发的特性，且复发事件的危害更严重于首发事件，目前研究已证实卒中二级预防治疗的药物和措施能有效减少脑卒中复发事件的发生，但是由于每个患者的病睛和卒中类型不同，每个患者间的卒中复发危险程度也存在差异，因此根据不同的预测量表来预测卒中患者的复发风险，临床上分层管理患者，更好地指导患者进行有效的二级预防是非常有价值的。
Stroke is a serious global public health problem, and ischemic stroke of accounts for 60-80%. It is well known that characteristics of ischemic stroke are high relapse and recurrence of events and are more harmful than the first event. The present study has confirmed that the secondary prevention of stroke treatment drugs and measures are effective in reducing the incidence of stroke recurrence events, and according to the conditions of patients and the type of stroke, the risk degree of recurrent stroke in patients are differences. Predicting the risk of stroke recurrence based on predictive scale, stratified clinical management of patients with better guidance and effective secondary prevention is very valuable.
出处
《中华脑血管病杂志（电子版）》
2013年第1期37-42,共6页
Chinese Journal of Cerebrovascular Diseases(Electronic Edition)
关键词
缺血性卒中
再发
预测
Ischemic stroke
Recurrence
Prediction
